BIOIF
Price
Day trading desk
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
3 more panels on BIOIF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2022 | 2021 | YoY |
|---|---|---|---|
| Total revenue | $0 | $0 | — |
| Operating revenue | $0 | $0 | — |
| Selling, general & admin | $609.65K | $1.01M | -39.8% |
| Total operating expense | $637.00K | $1.06M | -39.9% |
| Operating income | -$637.00K | -$1.06M | +39.9% |
| Net interest income | -$352.40K | -$453.54K | +22.3% |
| Pre-tax income | -$10.89M | -$139.93K | -7,680.6% |
| Net income | -$10.89M | -$139.93K | -7,680.6% |
| Net income to common | -$10.89M | -$139.93K | -7,680.6% |
| Basic EPS | -0.10 | -0.00 | -7,932.1% |
| Diluted EPS | -0.10 | -0.00 | -7,932.1% |
| EBIT | -$10.53M | $313.61K | -3,459.2% |
| EBITDA | -$10.53M | $313.61K | -3,459.2% |
| Basic shares | 112.42M | 112.42M | 0.0% |
| Diluted shares | 112.42M | 112.42M | 0.0% |
| Line item | 2022 | 2021 | YoY |
|---|---|---|---|
| Cash & equivalents | $101.67K | $582.30K | -82.5% |
| Cash & short-term investments | $332.43K | $9.41M | -96.5% |
| Total current assets | $462.66K | $11.01M | -95.8% |
| Total assets | $462.66K | $11.07M | -95.8% |
| Total current liabilities | $4.88M | $4.64M | +5.1% |
| Current debt | $4.16M | $3.51M | +18.5% |
| Total debt | $4.16M | $3.51M | +18.5% |
| Total liabilities | $4.88M | $4.64M | +5.1% |
| Retained earnings | -$30.19M | -$19.30M | -56.4% |
| Shareholder equity | -$4.42M | $6.43M | -168.8% |
| Working capital | -$4.42M | $6.36M | -169.5% |
| Net tangible assets | -$4.42M | $6.43M | -168.8% |
| Shares issued | 112.42M | 112.42M | 0.0% |
| Line item | 2022 | 2021 | YoY |
|---|---|---|---|
| Net income | -$10.89M | -$139.93K | -7,680.6% |
| Stock-based compensation | $37.16K | $52.33K | -29.0% |
| Change in working capital | -$141.02K | -$786.29K | +82.1% |
| Operating cash flow | -$742.68K | -$1.84M | +59.6% |
| Investing cash flow | $261.15K | $2.16M | -87.9% |
| Dividends paid | $0 | $0 | — |
| Financing cash flow | $0 | -$309.55K | +100.0% |
| Free cash flow | -$742.68K | -$1.84M | +59.6% |
| End cash position | $101.67K | $583.20K | -82.6% |
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.